Acro Biomedical Co., Ltd. (ACBM) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
12175 VISIONARY WAY FISHERS, IN 46038 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 79 - Amusement And Recreation Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 9/30/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 6 | 95 | 18 | 1 | |||||
| Cash and cash equivalent | 6 | 95 | 18 | 1 | |||||
| Inventory, net of allowances, customer advances and progress billings | 938 | 1,060 | |||||||
| Inventory | 938 | 1,060 | |||||||
| Prepaid expense | 1 | 1 | 1 | 1 | 3 | ||||
| Deposits current assets | 5 | ||||||||
| Other undisclosed current assets | 5 | 0 | 651 | 610 | 16 | ||||
| Total current assets: | 5 | 2 | 658 | 706 | 973 | 1,069 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 27 | 52 | 26 | 50 | 25 | ||||
| Other undisclosed noncurrent assets | 5 | 4 | 4 | ||||||
| Total noncurrent assets: | 27 | 57 | 30 | 55 | 25 | ||||
| TOTAL ASSETS: | 32 | 58 | 687 | 761 | 998 | 1,069 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 154 | 154 | 77 | 26 | 25 | 18 | |||
| Other undisclosed accounts payable and accrued liabilities | 154 | 154 | 77 | 26 | 25 | 18 | |||
| Deferred revenue | 20 | 20 | |||||||
| Other liabilities | 89 | ||||||||
| Due to related parties | ✕ | ✕ | ✕ | 79 | 21 | 243 | 62 | ||
| Other undisclosed current liabilities | 152 | 25 | 46 | 45 | 45 | 116 | |||
| Total current liabilities: | 327 | 289 | 201 | 92 | 312 | 196 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 26 | ||||||||
| Liabilities, other than long-term debt | 27 | ||||||||
| Operating lease, liability | 27 | 26 | |||||||
| Other undisclosed noncurrent liabilities | (26) | ||||||||
| Total noncurrent liabilities: | 27 | 26 | |||||||
| Total liabilities: | 327 | 315 | 201 | 117 | 312 | 196 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (295) | (257) | 486 | 644 | 686 | 874 | |||
| Common stock | 60 | 60 | 60 | 60 | 48 | 48 | |||
| Additional paid in capital | 32,303 | 32,298 | 32,295 | 32,294 | 877 | 871 | |||
| Deferred compensation equity | (8,061) | ||||||||
| Accumulated deficit | (32,658) | (32,615) | (23,808) | (7,936) | (239) | (45) | |||
| Other undisclosed equity, attributable to parent | (23,773) | ||||||||
| Total equity: | (295) | (257) | 486 | 644 | 686 | 874 | |||
| TOTAL LIABILITIES AND EQUITY: | 32 | 58 | 687 | 761 | 998 | 1,069 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 9/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 659 | 1,198 | 688 | 1,354 | ||||
| Cost of revenue | (518) | (938) | (529) | (1,219) | ||||
| Gross profit: | 141 | 260 | 159 | 135 | ||||
| Operating expenses | (38) | (8,804) | (16,010) | (7,953) | (290) | (577) | ||
| Operating loss: | (38) | (8,804) | (15,870) | (7,694) | (130) | (442) | ||
| Nonoperating expense | (4) | (3) | (5) | (2) | ||||
| Other nonoperating expense | (4) | (3) | ||||||
| Interest and debt expense | (0) | (1) | (5) | (2) | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 5 | 2 | ||||||
| Loss from continuing operations before equity method investments, income taxes: | (42) | (8,808) | (15,870) | (7,694) | (136) | (444) | ||
| Other undisclosed income from continuing operations before income taxes | ||||||||
| Loss from continuing operations before income taxes: | (42) | (8,808) | (15,870) | (7,694) | (136) | (444) | ||
| Income tax benefit | 18 | 73 | ||||||
| Loss from continuing operations: | (42) | (8,808) | (15,870) | (7,694) | (117) | (371) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (7,694) | (117) | (371) | |
| Other undisclosed net income | 17,615 | |||||||
| Net income (loss): | (42) | 8,808 | (15,870) | (7,694) | (117) | (371) | ||
| Other undisclosed net loss attributable to parent | (17,615) | (1) | (3) | |||||
| Net loss available to common stockholders, diluted: | (42) | (8,808) | (15,871) | (7,698) | (117) | (371) | ||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 9/30/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (42) | 8,808 | (15,870) | (7,694) | (117) | (371) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (42) | 8,808 | (15,870) | (7,694) | (117) | (371) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.